Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Market Cap	138.86B +1.0%
Revenue (ttm)	19.76B +23.5%
Net Income	1.26B +40.6%
EPS	3.96 +28.5%
Shares Out	316.96M
PE Ratio	110.51
Forward PE	83.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,965
Average Volume	186,325
Open	442.00
Previous Close	438.10
Day's Range	439.50 - 446.05
52-Week Range	327.00 - 568.00
Beta	n/a
RSI	52.58
Earnings Date	May 26, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AGARWALEYE

Financial Performance

In fiscal year 2025, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.